Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 198

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 198
---
 to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

    Signature
      
    Title
      
    Date

    /s/ David H. MackDavid H. Mack, Ph.D.
      
    President, Chief Executive Officer andDirector(Principal Executive Officer)
      
    March 3, 2025

    /s/ Michael CarulliMichael Carulli
      
    Chief Financial Officer(Principal Financial and Accounting Officer)
      
    March 3, 2025

    /s/ Richard HeymanRichard Heyman, Ph.D.
      
    Director and Chairman of the Board ofDirectors
      
    March 3, 2025

    /s/ Arnold LevineArnold Levine, Ph.D.
      
    Director
      
    March 3, 2025

    /s/ Carol GallagherCarol Gallagher, Ph.D.
      
    Director
      
    March 3, 2025

    /s/ Laurie StelzerLaurie Stelzer
      
    Director
      
    March 3, 2025

    /s/ Charles M. BaumCharles M. Baum, MD., Ph.D.
      
    Director
      
    March 3, 2025

    /s/ Kirsten Flowers
     
    Director
     
    March 3, 2025

    Kirsten Flowers

 130